Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
AOD-9604 was developed to: Stimulate lipolysis (breakdown of stored fat) Inhibit lipogenesis (formation of new fat) Avoid raising IGF-1 levels Reduce impact on blood glucose Because it is a small fragment rather than the full hormone, it theoretically targets fat metabolism more specifically
Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma
Verify batch identity (MS confirmed) and purity (99% HPLC) before use
WHAT IS BPC-157 and TB-500 USED FOR
Some clinicians overlap the medications briefly during the transition, continuing phentermine while semaglutide titrates up, then discontinuing phentermine once semaglutide reaches therapeutic levels
US$ 21.52
US$ 27.66
US$ 24.08
US$ 20.63
US$ 26.29
